Atención médica de calidadDescubra por qué Mayo Clinic es el mejor lugar para atenderse. Pide una cita.
Aref Al-Kali, M.D., is an expert in myeloid neoplasms and develops new therapies for myelodysplastic syndromes and acute myeloid leukemia. He researches molecular signatures of myelodysplastic syndromes and acute myeloid leukemia to understand these conditions and improve treatments.
Trials pave the way for better medicine with less toxicity. Dr. Al-Kali aids in the approval of oral drugs that help in the care of myelodysplastic syndromes. He also was the first to raise the possibility of watch and wait in certain molecular signatures or markers. Dr. Al-Kali's published research that compares real-world experience with clinical trials data concerning myeloid neoplasms provides relevant information that helps further the understanding of myelodysplastic syndromes.
Infórmate sobre los ensayos clínicos que abordan preguntas científicas específicas sobre la salud humana y las enfermedades.
Ver mis estudios.
Explora todos los estudios de investigación en Mayo Clinic.
Ver las conclusiones revisadas por colegas que publiqué como resultado de mi investigación.